[Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D001812:Blood-Brain Barrier; D002395:Catecholamines / Q000502:physiology; D055598:Chemical Phenomena; D002621:Chemistry; D002799:Cholinergic Fibers / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D008253:Macaca mulatta; D008543:Melanins / Q000378:metabolism; D009457:Neuroglia / Q000378:metabolism; D009474:Neurons / Q000187:drug effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects* / Q000378:metabolism; D013329:Structure-Activity Relationship
D002395:Catecholamines; D008543:Melanins; D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine